Asahi Intecc Co Ltd
TSE:7747
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
682.5B JPY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
60B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.9T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
29.6B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
109.6B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.9B CHF |
Loading...
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD |
Loading...
|
Market Distribution
| Min | -122 700% |
| 30th Percentile | 2.9% |
| Median | 5.4% |
| 70th Percentile | 8.5% |
| Max | 63 031.4% |
Other Profitability Ratios
Asahi Intecc Co Ltd
Glance View
Asahi Intecc Co., Ltd. stands at the intersection of precision engineering and medical innovation, carving a niche in the specialized realm of guide wires and catheters, essential tools in the field of cardiovascular interventions. The company, rooted in Japan, has harnessed its expertise in ultra-fine stainless steel wire ropes—a technology initially honed for industrial purposes—to revolutionize medical devices. Unlike many in the industry, Asahi Intecc integrates its manufacturing vertically, producing components in-house to maintain high standards of quality and performance. This meticulous approach ensures that its products meet the demanding specifications of the medical community. Beyond its cornerstone medical division, the company extends its reach into industrial fields such as robotics and consumer electronics, where its high-precision capabilities are equally prized. The financial scaffolding of Asahi Intecc is built on its ability to consistently deliver innovative solutions that address the needs of an aging global population increasingly susceptible to cardiovascular ailments. Its robust R&D initiatives are pivotal in sustaining its competitive edge, fostering the development of next-generation medical devices that cater to the complex demands of advanced medical procedures. The company capitalizes on a global distribution network, allowing it to tap into burgeoning markets across Asia, Europe, and the Americas. Revenue streams are diversified across product sales, royalties, and collaborative ventures, with significant investments channeled back into research, ensuring that Asahi Intecc maintains a cycle of continuous improvement and adaptation in the fast-evolving med-tech landscape.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Asahi Intecc Co Ltd is 12.1%, which is below its 3-year median of 14%.
Over the last 3 years, Asahi Intecc Co Ltd’s Net Margin has decreased from 14.1% to 12.1%. During this period, it reached a low of 8.9% on Mar 31, 2025 and a high of 15.9% on Dec 31, 2024.